Treatment of Janus kinase inhibitors in rheumatoid arthritis
-
- YAMAGUCHI Shinichi
- Medical corporation Yamaguchi Clinic
Bibliographic Information
- Other Title
-
- 関節リウマチにおけるヤヌスキナーゼ阻害薬の治療
Abstract
<p>The author examined the use of Janus kinase (JAK) inhibitors in patients with rheumatoid arthritis (RA) at our hospital: 8 patients were treated with tofacitinib, and 5 were treated with baricitinib. The tofacitinib treatment group consisted of 2 treatment-naïve patients and 6 patients switched from another treatment. Currently, tofacitinib treatment is being continued in 4 patients, and baricitinib treatment in 3 patients. The proportion of female patients was higher. The patients in this study were elderly. Methotrexate (MTX) was used in all patients. An improvement in the modified Health Assessment Questionnaire (mHAQ) score was observed with both drugs. Herpes zoster occurred in 5 patients receiving tofacitinib and 1 patient receiving baricitinib. In this report, patients treated with JAK inhibitors are presented and discussed.</p>
Journal
-
- The Journal of the Japanese Clinical Orthopaedic Association
-
The Journal of the Japanese Clinical Orthopaedic Association 45 (1), 69-70, 2020
The Japanese Clinical Orthopaedic Association
- Tweet
Details 詳細情報について
-
- CRID
- 1390848250131139456
-
- NII Article ID
- 130007879685
-
- ISSN
- 21897905
- 18817149
-
- Text Lang
- ja
-
- Data Source
-
- JaLC
- CiNii Articles
-
- Abstract License Flag
- Disallowed